PA (pseudomonas aeruginosa) recombinant protein Vac33, as well as preparation method and application thereof

A Pseudomonas aeruginosa, recombinant protein technology, applied in biochemical equipment and methods, chemical instruments and methods, recombinant DNA technology, etc., to achieve mild purification conditions, good immune protection effect, maintain spatial conformation and immunogenicity. Effect

Active Publication Date: 2016-07-06
ARMY MEDICAL UNIV
View PDF9 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Similarly, PcrV is also an important candidate vaccine molecule, but due to its ability to form homologous mul

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • PA (pseudomonas aeruginosa) recombinant protein Vac33, as well as preparation method and application thereof
  • PA (pseudomonas aeruginosa) recombinant protein Vac33, as well as preparation method and application thereof
  • PA (pseudomonas aeruginosa) recombinant protein Vac33, as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Example 1 Construction and Identification of Recombinant Plasmids

[0034] 1. The synthesis of the DNA sequence of Vac33 and the connection of the sequence and pGEX-6p-2 were synthesized by Shanghai Sangon Bioengineering Co., Ltd.

[0035] 2. Transformation of recombinant plasmids

[0036] Take 3 tubes of Escherichia coli XL1blue competent cells (Shanghai Chaoyan Biotechnology Co., Ltd.) from the -80°C refrigerator, add pGEX-6P-2 plasmid (GE Healthcare Life Sciences) to the first tube as a positive control; add 1ulVac33 synthetic plasmid to the second tube; No exogenous DNA was added to the third tube as a negative control. Ice bath for 50min, heat shock in 42℃ metal bath for 90s, rapid ice bath for 2min. Add 600 μl LB blank medium, mix well, and place in a shaker at 37°C at 220rp for 1h.

[0037] Each tube was centrifuged at 5000 rpm for 3 min at room temperature, discarded 300 μl of supernatant, and then resuspended the bacteria, took 200 μl and spread it on an A...

Embodiment 2

[0043] Example 2 Induced expression, purification and identification of expression form of recombinant fusion protein PcrV-OprI in prokaryotic expression system-Escherichia coli

[0044] 1. Vac33 induced expression

[0045] Take 100 μL of the overnight cultured pGEX-6P-2-Vac33 / XL-1blue bacterial solution and add it to 10 mL of Amp+ resistant LB medium, culture overnight at 180 rpm at 37°C, respectively take 400 μL of the overnight cultured bacterial solution and add it to 20 mL of Amp+ resistant LB medium (The rest of the bacterial solution is stored in a refrigerator at 4°C for later use), culture at 37°C for 2-3 hours, rotate at 200 rpm, and reactivate until the OD600 is 0.8-1.0, add 4 μL of IPTG to make the final concentration 200 μM, and place on a shaker Induced expression Induced expression at 30°C for 3h.

[0046] 2) Take out the bacterial solution after induced expression, centrifuge at 12000rpm for 5min, discard the supernatant, add 1mL of lysisbuffer (20mMPB, pH7....

Embodiment 3Va

[0053] The preparation of embodiment 3Vac33 antigen

[0054] 1. Amplify culture to obtain protein

[0055] Take 400 μL of the spare pGEX-6P-2-Vac33 / XL-1blue bacterial solution stored in the refrigerator at 4°C and add it to 20mL LB medium containing Amp resistance for one activation. After culturing at 200rpm for 5-6 hours at 37°C, take 8mL once The activated bacterial solution was added to 400mL LB medium containing Amp resistance for secondary activation, cultured at 37°C for 3-4h until the OD600 was 1.0, then added 80μLPTG (final concentration 200μM) and placed in a shaker at 16°C overnight to induce Afterwards, 12000rpm centrifugal 15min collects thalline, adds 20mLlysisbuffer (same as embodiment 2) after resuspending thalline, bacterium liquid is carried out ultrasonic cracking 3min (200V), collect supernatant and GlutathioneSepharose4B (GE Company) gel beads (beads) binding treatment; then SDS-PAGE gel electrophoresis.

[0056] 2. Use the enzyme digestion method to sep...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides recombinant protein. The recombinant protein is formed by fusion of a PA III type secretory system component protein (PcrV) fragment and a PA outer membrane lipoprotein (OprI) fragment through a Linker, and has a general formula: PcrV fragment-(Linker)n-Oprl fragment, wherein the sequence of the Linker is selected from one of GGGGS, GGSGG and YAPVDV, and preferentially GGGGS; n is 1, 2, 3 or 4, and preferentially 1. The invention also provides a preparation method and an application of the recombinant protein. Subunit vaccine prepared from the recombinant protein can stimulate the organism to generate high-titer IgG antibodies; the recombinant protein can be used for preparing diagnostic reagents, and preventive or therapeutic drugs.

Description

technical field [0001] The invention belongs to the field of biotechnology and pharmacy, and specifically relates to a recombinant protein Vac33 (PcrV-OprI) of Pseudomonas aeruginosa, and further relates to a preparation method and application of the recombinant protein. Background technique [0002] Pseudomonas aeruginosa (Pseudomonas aeruginosa, PA), commonly known as Pseudomonas aeruginosa, belongs to the genus Pseudomonas in non-fermenting bacteria. It is ubiquitous and is one of the most common opportunistic pathogens in clinical practice. At present, the bacterium has become one of the pathogenic bacteria with the highest isolation rate in ICU wards, burns, war trauma infections, and mechanical ventilation-associated pneumonia (VAP) worldwide. PA infection can occur in any part and tissue of the human body, such as burns or trauma, middle ear, cornea, urethra, and respiratory tract, etc., and can also cause systemic infections such as endocarditis, gastroenteritis, pn...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K19/00C12N15/70A61K39/104A61P31/04G01N33/569
CPCA61K39/104A61K2039/54A61K2039/545C07K14/21C07K2319/00C12N15/70C12N2800/101G01N33/56911G01N2333/21
Inventor 顾江章金勇邹全明赵莉群杨茜杨峰彭六生吴翼王逸麟
Owner ARMY MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap